Literature DB >> 22584649

Ethylmalonic encephalopathy associated with crescentic glomerulonephritis.

Imad Dweikat1, Enas Naser, Nadera Damsah, Bassam Abu Libdeh, Izzeddin Bakri.   

Abstract

Ethylmalonic encephalopathy (EE) is a rare autosomal recessive disorder caused by mutations in the ETHE1 gene and characterized by chronic diarrhea, encephalopathy, relapsing petechiae and acrocyanosis. Nephrotic syndrome has been described in an infant with EE but the renal histology findings were not described in previous reports. We report a Palestinian girl with EE who presented with chronic diarrhea, encephalopathy, petechial rash and acrocyanosis. Subsequently, she developed progressive deterioration of renal function caused by rapidly progressive glomerulonephritis resulting in death within few days. This is, to our knowledge, the first reported occurrence of rapidly progressive glomerulonephritis in a child with ethylmalonic encephalopathy. Its presence is a serious complication associated with poor prognosis and may be explained by the diffuse vascular damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584649     DOI: 10.1007/s11011-012-9313-y

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  9 in total

1.  A case of ethylmalonic encephalopathy with atypical clinical and biochemical presentation.

Authors:  Maja Di Rocco; Ubaldo Caruso; Egill Briem; Andrea Rossi; Anna E M Allegri; Davide Buzzi; Valeria Tiranti
Journal:  Mol Genet Metab       Date:  2006-07-07       Impact factor: 4.797

2.  Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy.

Authors:  Carlo Viscomi; Alberto B Burlina; Imad Dweikat; Mario Savoiardo; Costanza Lamperti; Tatjana Hildebrandt; Valeria Tiranti; Massimo Zeviani
Journal:  Nat Med       Date:  2010-07-25       Impact factor: 53.440

3.  Clinical heterogeneity in ethylmalonic encephalopathy.

Authors:  Nicole Pigeon; Philippe M Campeau; Denis Cyr; Bernard Lemieux; Joe T R Clarke
Journal:  J Child Neurol       Date:  2009-03-16       Impact factor: 1.987

4.  Clinical spectrum and outcome of crescentic glomerulonephritis in children in developing countries.

Authors:  Deepak Dewan; Sanjeev Gulati; Raj K Sharma; Narayan Prasad; Manoj Jain; Amit Gupta; Alok Kumar
Journal:  Pediatr Nephrol       Date:  2007-12-11       Impact factor: 3.714

5.  Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy.

Authors:  Valeria Tiranti; Carlo Viscomi; Tatjana Hildebrandt; Ivano Di Meo; Rossana Mineri; Cecilia Tiveron; Michael D Levitt; Alessandro Prelle; Gigliola Fagiolari; Marco Rimoldi; Massimo Zeviani
Journal:  Nat Med       Date:  2009-01-11       Impact factor: 53.440

6.  Incidence and prognostic importance of glomerular crescents in renal diseases of childhood.

Authors:  M N Miller; R Baumal; S Poucell; B T Steele
Journal:  Am J Nephrol       Date:  1984       Impact factor: 3.754

7.  Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy.

Authors:  Carla Giordano; Carlo Viscomi; Maurizia Orlandi; Paola Papoff; Alberto Spalice; Alberto Burlina; Ivano Di Meo; Valeria Tiranti; Vincenzo Leuzzi; Giulia d'Amati; Massimo Zeviani
Journal:  J Inherit Metab Dis       Date:  2011-10-22       Impact factor: 4.982

8.  ETHE1 mutations are specific to ethylmalonic encephalopathy.

Authors:  V Tiranti; E Briem; E Lamantea; R Mineri; E Papaleo; L De Gioia; F Forlani; P Rinaldo; P Dickson; B Abu-Libdeh; L Cindro-Heberle; M Owaidha; R M Jack; E Christensen; A Burlina; M Zeviani
Journal:  J Med Genet       Date:  2005-09-23       Impact factor: 6.318

9.  Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein.

Authors:  Valeria Tiranti; Pio D'Adamo; Egill Briem; Gianfrancesco Ferrari; Rossana Mineri; Eleonora Lamantea; Hanna Mandel; Paolo Balestri; Maria-Teresa Garcia-Silva; Brigitte Vollmer; Piero Rinaldo; Si Houn Hahn; James Leonard; Shamima Rahman; Carlo Dionisi-Vici; Barbara Garavaglia; Paolo Gasparini; Massimo Zeviani
Journal:  Am J Hum Genet       Date:  2004-01-19       Impact factor: 11.025

  9 in total
  3 in total

1.  Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine.

Authors:  Mustafa Kılıç; Özge Dedeoğlu; Rahşan Göçmen; Selman Kesici; Deniz Yüksel
Journal:  Metab Brain Dis       Date:  2016-11-09       Impact factor: 3.584

2.  Severe early onset ethylmalonic encephalopathy with West syndrome.

Authors:  Laura Papetti; Giacomo Garone; Livia Schettini; Carla Giordano; Francesco Nicita; Paola Papoff; Massimo Zeviani; Vincenzo Leuzzi; Alberto Spalice
Journal:  Metab Brain Dis       Date:  2015-07-21       Impact factor: 3.584

3.  Neurological and Vascular Manifestations of Ethylmalonic Encephalopathy.

Authors:  Ali Reza Tavasoli; Parastoo Rostami; Mahmoud Reza Ashrafi; Parvaneh Karimzadeh
Journal:  Iran J Child Neurol       Date:  2017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.